Comparative biodistributions and rates of catabolism of radiolabelled anti-CEA monoclonal antibody and control immunoglobulin in nude mice with human tumour xenografts showing specific antibody localization
β Scribed by M. V. Pimm; R. W. Baldwin
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 555 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
The rate of catabolism of a radiolabelled monoclonal anti-CEA antibody has been compared with that of control IgG1 in control nude mice and in mice with CEA producing xenografts and antigen negative xenografts. The rate of catabolism of antibody, but not of IgG, was increased 3-4 fold in mice with xenografts localizing the antibody, but not in mice with antigen negative tumours. There was no evidence of immune complex formation and/or clearance of antibody from the serum of xenografted mice and the current interpretation of these findings is that following tumour immune directed fixation, antibody is subsequently catabolized faster than in the general metabolic pool. The present data indicates that this is about six times as rapid as in the animal as a whole on a weight to weight tissue basis.
π SIMILAR VOLUMES
The blood kinetics and tissue distribution of a conjugate of daunomycin and a monoclonal antibody (791T/36) have been examined in mice, including nude mice with human tumour xenografts reactive with the antibody. For this the antibody moiety of the conjugate was labelled with 125I and the drug moiet
The blood kinetics and tumour localization of a conjugate of methotrexate (MTX) and MAb 791T136 were examined i n nude mice with human tumour xenografts. The antibod moiety of the conjugate was detected by labelling with l2J and the drug moiety was assayed using a radioimmunoassay for methotrexate.
## Abstract Carbonic anhydrase IX (CA IX) is frequently expressed in human carcinomas and absent from the corresponding normal tissues. Strong induction by tumor hypoxia predisposes CA IX to serve as a target for cancer diagnostics and therapy. Here we evaluated targeting properties and pharmacokin